Development
Semler Scientific, Inc.
SMLR
$30.25
-$1.18-3.75%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 15.06M | 16.32M | 18.61M | 18.21M | 13.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.06M | 16.32M | 18.61M | 18.21M | 13.80M |
| Cost of Revenue | 3.39M | 1.11M | 1.22M | 1.27M | 1.18M |
| Gross Profit | 11.67M | 15.21M | 17.39M | 16.94M | 12.61M |
| SG&A Expenses | 7.81M | 7.13M | 8.44M | 9.05M | 7.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.40M | 9.42M | 11.43M | 11.95M | 10.18M |
| Operating Income | 2.66M | 6.90M | 7.18M | 6.26M | 3.62M |
| Income Before Tax | 2.81M | 6.99M | 7.67M | 6.63M | 3.96M |
| Income Tax Expenses | -1.41M | 1.47M | 1.79M | 1.66M | 741.00K |
| Earnings from Continuing Operations | 4.22M | 5.51M | 5.88M | 4.97M | 3.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.22M | 5.51M | 5.88M | 4.97M | 3.22M |
| EBIT | 2.66M | 6.90M | 7.18M | 6.26M | 3.62M |
| EBITDA | 2.74M | 7.06M | 7.33M | 6.39M | 3.67M |
| EPS Basic | 0.62 | 0.82 | 0.88 | 0.74 | 0.48 |
| Normalized Basic EPS | 0.31 | 0.71 | 0.72 | 0.63 | 0.37 |
| EPS Diluted | 0.54 | 0.71 | 0.75 | 0.63 | 0.41 |
| Normalized Diluted EPS | 0.27 | 0.61 | 0.62 | 0.53 | 0.31 |
| Average Basic Shares Outstanding | 6.81M | 6.72M | 6.71M | 6.70M | 6.69M |
| Average Diluted Shares Outstanding | 7.73M | 7.82M | 7.87M | 7.90M | 7.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |